General MedicationsINTRAVENOUSGeneric

NATRECOR

NESIRITIDE

Standard Dose

1.5MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview NATRECOR is listed in Drugs@FDA under application 020920 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient NESIRITIDE Form and strength FOR SOLUTION;INTRAVENOUS - 1.5MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SCIOS LLC Submission history Latest submission status date: 2019-01-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview NATRECOR is listed in Drugs@FDA under application 020920 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient NESIRITIDE Form and strength FOR SOLUTION;INTRAVENOUS - 1.5MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SCIOS LLC Submission history Latest submission status date: 2019-01-09 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.